ID: MRFR/HC/7025-HCR | February 2021 | Region: Global | 90 pages
H. Pylori (Helicobacter Pylori) Test Market is expected to hold a value of USD 2,924.2 Million by 2025 at a CAGR of 5.2%.
Helicobacter pylori tests are used to detect an H. pylori infection in the stomach and upper part of the small intestine (duodenum). There has been a high burden of helicobacter pylori across the world. H. pylori infection is one of the world's most common an. In 2019, the prevalence of H. pylori infection reported a wide range from 18.9% in Switzerland up to 87.7% in Nigeria.
In 2015, the worldwide prevalence of H. pylori was 4.4 billion individuals, and currently, it ranges between 85% and 95% in developing countries and between 30 and 50% (out of total population) in developed countries. Thus, the worldwide prevalence of H. pylori would influence the market growth during the study period. Global rising incidence of H. pylori infections accompanied by dyspepsia, availability of diagnostic tests, the presence of contaminated water or food, poor sanitation, high dense population, and poor personal hygiene are the factors expected to support the market growth over the assessment period.
By Test Type
Frequently Asked Questions (FAQ) :
H. Pylori (helicobacter pylori) test market is projected grow at approximately 5.2% CAGR during the assessment period (2019-2025).
The valuation of the global H. Pylori (helicobacter pylori) test market is estimated to increase to USD 2,924.2 MN by the end of 2025.
The non-endoscopic segment by type holds the majority shares in the global H. Pylori (helicobacter pylori) test market.
North America holds the largest share in the global H. Pylori (helicobacter pylori) test market, followed by Europe and the Asia Pacific, respectively.
Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Quest Diagnostics Incorporated (US), Meridian Bioscience (US), F. Hoffmann-La Roche Ltd (Switzerland), CorisBioconcept SPRL (Belgium), Abbott Laboratories (US), Biohit Oyj (Finland), and Cardinal Health (US), QIAGEN (Germany), are some of the major players operating in the global H. Pylori (helicobacter pylori) test market.
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.